Palvella Therapeutics (PVLA) Shares Outstanding (Diluted Average) (2020 - 2024)
Historic Shares Outstanding (Diluted Average) for Palvella Therapeutics (PVLA) over the last 5 years, with Q3 2024 value amounting to $1.8 million.
- Palvella Therapeutics' Shares Outstanding (Diluted Average) rose 4321.74% to $1.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.8 million, marking a year-over-year increase of 4321.74%. This contributed to the annual value of $64.5 million for FY2021, which is 1847.62% up from last year.
- Palvella Therapeutics' Shares Outstanding (Diluted Average) amounted to $1.8 million in Q3 2024, which was up 4321.74% from $1.8 million recorded in Q2 2024.
- Over the past 5 years, Palvella Therapeutics' Shares Outstanding (Diluted Average) peaked at $74.1 million during Q2 2022, and registered a low of $1.1 million during Q2 2023.
- Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $54.4 million (2020), whereas its average is $40.6 million.
- Per our database at Business Quant, Palvella Therapeutics' Shares Outstanding (Diluted Average) tumbled by 9851.87% in 2023 and then surged by 6121.74% in 2024.
- Over the past 5 years, Palvella Therapeutics' Shares Outstanding (Diluted Average) (Quarter) stood at $54.5 million in 2020, then increased by 18.48% to $64.5 million in 2021, then grew by 14.84% to $74.1 million in 2022, then tumbled by 98.33% to $1.2 million in 2023, then soared by 43.22% to $1.8 million in 2024.
- Its Shares Outstanding (Diluted Average) was $1.8 million in Q3 2024, compared to $1.8 million in Q2 2024 and $1.8 million in Q1 2024.